Code of conduct
A register that takes money from some of the companies it writes about has to be specific about what that money buys, because the obvious suspicion is the correct one to have. This page is that specification. It is written so you can catch us breaking it.
What the money buys, and what it does not
Several sellers in this register pay a commission when a reader signs up through a link here. That is how the site is funded, and it is disclosed on the row it applies to rather than in a footer.
What commission affects: order. Paying partners are grouped ahead of non-partners on twelve category boards, on the main register, and in the homepage slot. We say so on each of those surfaces. Anyone claiming their placement is purely editorial while doing this is lying, and we would rather be blunt than be that.
What it does not affect: the score, the findings, the warning letters, the price we publish, or whether a damaging fact runs at all. Scoring runs identically over every seller in the register, partner or not, and the weights are public on the methodology page.
When a partner objects
It happens. The rule is that we will argue about facts and nothing else. Show us that a price is wrong, that a letter was addressed to a different company, that a registration lapsed and was reinstated, and we will check it and correct it the same day if you are right.
Tell us a finding is unfair, damaging or bad for business, and the answer is no. We will not remove a verified fact, soften a verdict, or delay publication because of a commercial relationship, and ending that relationship does not change the coverage either. A seller who leaves the program keeps their review, their score and their warning letters.
No seller sees a review before it publishes. We will check a specific fact with a company by email. We will not send them the draft.
Where the facts come from
Every claim here is supposed to carry the document it came from: an FDA warning letter with its case number, a state pharmacy board record, an outsourcing facility registration, a trial paper with its PMID, or a price read off the seller’s own checkout on a recorded date. A watchdog has no authority of its own. All of it is borrowed from what it can show you.
Two practices follow from that. We re-verify rather than inherit — a citation copied from somewhere else is an error you have not checked yet. And a price is published with the date it was captured, because a figure without a date is not a fact about today.
Clinical material is currently reviewed editorially and not by a clinician, and every page carrying it says so plainly rather than implying otherwise. We are looking for a clinical reviewer to change that.
Conflicts
Nobody who writes here may hold equity in a seller they cover, and anyone with a financial interest in a company has to say so before touching the file. We take no payment for a score, a rank, or a form of words. We accept no travel, hospitality or gifts from sellers. Sample product is bought, not accepted, when buying it is the only way to see what a customer actually receives.
Nothing here runs as paid editorial. If a page were ever sponsored it would be labeled at the top, and at present no such page exists.
Getting it wrong
We will. When a published fact turns out to be wrong we fix the page and say what changed and when, on the page itself, rather than editing quietly. The corrections log is public and includes the mistakes that were embarrassing.
If a seller misled us and we printed it, the correction says that too, and names them.
Reporting us
Send the page URL and what is wrong with it to conduct@glpwatchdog.org. Factual errors get checked first and fastest. Allegations that we have taken money for a ranking, hidden a conflict, or pulled a finding under pressure get investigated, and if any of it is true we will publish that finding about ourselves.
There is no comments section and no forum, so there is nothing to moderate. If that changes this page will change with it.